Back to results
US 5,514,775 AGranted
Chromogranin peptides
AssigneeAlbert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University
InventorsRuth Hogue-Angeletti, John Russell
Life of this patent
Estimating the term…
Abstract
This invention relates to the preparation and use of shortened synthetic chromogranin peptides capable of inhibiting parathyroid hormone secretion. The shortened synthetic chromogranin peptides of the invention are administered to treat hyperparathyroidism and to reverse bone resorption.
Claims1
A synthetic chromogranin A peptide having the amino acid sequence Cys Ile Val Glu Val Ile Ser Asp Thr Leu Ser Lys Pro Ser Pro Met Pro Val Ser Lys Glu Cys (SEQ ID NO:
- 3).
Dependencies are inferred from the claim text.